MobiHealth News February 14, 2024
According to the bankruptcy petition, the company has liabilities of $1 billion to $10 billion with assets of $500 million to $1 billion.
Invitae, a medical genetic testing company, has filed for Chapter 11 bankruptcy and intends to continue the case without disrupting operations using cash on hand and while seeking to sell its business.
The San Francisco-based company is seeking approval from the U.S. Bankruptcy Court for the District of New Jersey to use its cash on hand to fund the case.
In its bankruptcy petition, the company listed assets of $500 million to $1 billion, but liabilities of $1 billion to $10 billion.
“We have been working diligently over the past eighteen months to improve...